- NCIt
- C4879
Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01221376 | Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+) | unknown | Phase 2 | 20 | Renato MelaragnoOTHER | 1 | Mar 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Mar 26, 2013source: clinicaltrials